The association and predictive value analysis of metabolic syndrome on diastolic heart failure in patients at high risk for coronary artery disease

Diabetology and Metabolic Syndrome

Volumn 5, Issue 1, 2013, Pages

  Tang, Zi Hui ^a   Zeng, Fangfang ^a   Li, Zhongtao ^a   Si, Yibing ^a   Zhou, Linuo ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Association; Coronary artery disease; Diastolic heart failure; High risk patients; Metabolic syndrome

Indexed keywords

TRIACYLGLYCEROL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DIASTOLIC HEART FAILURE; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREDICTIVE VALUE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84879195087     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-5-30     Document Type: Article

References (24)

1. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. Lakka HM, Laaksonen DE, Lakka TA, et al. JAMA 2002 288 2709 2716 10.1001/jama.288.21.2709 12460094 (Pubitemid 35403784)
2. Clinical practice. Diastolic heart failure. Aurigemma GP, Gaasch WH, N Engl J Med 2004 351 1097 1105 10.1056/NEJMcp022709 15356307 (Pubitemid 39172207)
3. Outcome of heart failure with preserved ejection fraction in a population-based study. Bhatia RS, Tu JV, Lee DS, et al. N Engl J Med 2006 355 260 269 10.1056/NEJMoa051530 16855266 (Pubitemid 44088349)
4. Trends in prevalence and outcome of heart failure with preserved ejection fraction. Owan TE, Hodge DO, Herges RM, et al. N Engl J Med 2006 355 251 259 10.1056/NEJMoa052256 16855265 (Pubitemid 44079340)
5. Cardiac dysfunction assessed by echocardiographic tissue Doppler imaging is an independent predictor of mortality in the general population. Mogelvang R, Sogaard P, Pedersen SA, et al. Circulation 2009 119 2679 2685 10.1161/CIRCULATIONAHA.108.793471 19433761
6. Comparison of cardiac structure and function in American Indians with and without the metabolic syndrome (the Strong Heart Study). Chinali M, Devereux RB, Howard BV, et al. Am J Cardiol 2004 93 40 44 14697463 (Pubitemid 38028620)
7. Patients with early diabetic heart disease demonstrate a normal myocardial response to dobutamine. Fang ZY, Najos-Valencia O, Leano R, et al. J Am Coll Cardiol 2003 42 446 453 10.1016/S0735-1097(03)00654-5 12906970 (Pubitemid 36951709)
8. Association of left ventricular hypertrophy with metabolic risk factors: the HyperGEN study. de Simone G, Palmieri V, Bella JN, et al. J Hypertens 2002 20 323 331 10.1097/00004872-200202000-00024 11821719 (Pubitemid 34913799)
9. Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Grundy SM, Hansen B, Smith SC Jr, et al. Circulation 2004 109 551 556 10.1161/01.CIR. 0000112379.88385.67 14757684 (Pubitemid 38168522)
10. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Dickstein K, Cohen-Solal A, Filippatos G, et al. Eur J Heart Fail 2008 10 933 989 10.1016/j.ejheart.2008.08.005 18826876
11. Metabolic syndrome is associated with abnormal left ventricular diastolic function independent of left ventricular mass. de las Fuentes L, Brown AL, Mathews SJ, et al. Eur Heart J 2007 28 553 559 17311827 (Pubitemid 47355514)
12. Insulin resistance and inflammatory activation in older patients with systolic and diastolic heart failure. Wisniacki N, Taylor W, Lye M, et al. Heart 2005 91 32 37 10.1136/hrt.2003.029652 15604330 (Pubitemid 39664989)
13. Relationship between insulin resistance and left ventricular diastolic dysfunction in patients with impaired glucose tolerance and type 2 diabetes. Bajraktari G, Koltai MS, Ademaj F, et al. Int J Cardiol 2006 110 206 211 10.1016/j.ijcard.2005.08.033 16297997 (Pubitemid 43786377)
14. Insulin resistance and risk of congestive heart failure. Ingelsson E, Sundstrom J, Arnlov J, et al. JAMA 2005 294 334 341 10.1001/jama.294.3.334 16030278 (Pubitemid 41043777)
15. Insulin resistance and glycemic abnormalities are associated with deterioration of left ventricular diastolic function: a cross-sectional study. Dinh W, Lankisch M, Nickl W, et al. Cardiovasc Diabetol 2010 9 63 10.1186/1475-2840-9-63 20950415
16. Diabetic cardiomyopathy revisited. Boudina S, Abel ED, Circulation 2007 115 3213 3223 10.1161/CIRCULATIONAHA.106.679597 17592090 (Pubitemid 47012236)
17. The pathobiology of diabetic complications: a unifying mechanism. Brownlee M, Diabetes 2005 54 1615 1625 10.2337/diabetes.54.6.1615 15919781 (Pubitemid 40770750)
18. Myocardial insulin action and the contribution of insulin resistance to the pathogenesis of diabetic cardiomyopathy. Ouwens DM, Diamant M, Arch Physiol Biochem 2007 113 76 86 10.1080/13813450701422633 17558606 (Pubitemid 46904761)
19. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Houstis N, Rosen ED, Lander ES, Nature 2006 440 944 948 10.1038/nature04634 16612386
20. Treatment of isolated left ventricular diastolic dysfunction in hypertension: reaching blood pressure target matters. Palmieri V, Russo C, Bella JN, Hypertension 2010 55 224 225 10.1161/HYPERTENSIONAHA.109.144717 19996064
21. The clinical implications of endothelial dysfunction. Widlansky ME, Gokce N, Keaney JF Jr, et al. J Am Coll Cardiol 2003 42 1149 1160 10.1016/S0735-1097(03)00994-X 14522472 (Pubitemid 37188333)
22. Management of left ventricular diastolic heart failure: is it only blood pressure control? Koprowski A, Gruchala M, Rynkiewicz A, Curr Opin Cardiol 2009 24 161 166 10.1097/HCO.0b013e328320d530 19532103
23. The importance of diastolic blood pressure in predicting cardiovascular risk. Franklin SS, J Am Soc Hypertens 2007 1 82 93 10.1016/j.jash.2006.11.004 20409835 (Pubitemid 46705223)
24. Obesity and left ventricular dilatation in young adulthood: the Bogalusa Heart Study. Bazzano LA, Belame SN, Patel DA, et al. Clin Cardiol 2011 34 153 159 10.1002/clc.20896 21400542